16,014 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by FORA Capital LLC

FORA Capital LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 16,014 shares of the biotechnology company's stock, valued at approximately $9,517,000. Axon Enterprise comprises about 1.1% of FORA Capital LLC's investment portfolio, making the stock its 17th largest holding.

Other hedge funds and other institutional investors have also modified their holdings of the company. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise in the fourth quarter valued at $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the 4th quarter worth about $45,000. Stonebridge Financial Group LLC purchased a new stake in Axon Enterprise during the fourth quarter worth approximately $53,000. GPS Wealth Strategies Group LLC lifted its stake in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $59,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Axon Enterprise stock traded down $2.24 during trading hours on Friday, reaching $684.59. 642,401 shares of the stock were exchanged, compared to its average volume of 764,683. The stock has a market cap of $53.29 billion, a P/E ratio of 176.90, a P/E/G ratio of 5.17 and a beta of 1.24. The firm's 50 day moving average is $564.50 and its 200 day moving average is $584.84. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm's revenue was up 31.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.15 earnings per share. Analysts predict that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Barclays boosted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Finally, Needham & Company LLC raised their price target on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and a consensus target price of $640.91.

Insider Buying and Selling at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.